| scholarly article | Q13442814 |
| P50 | author | Jeffery W. Kelly | Q6175781 |
| Sunil M Kurian | Q46181458 | ||
| Marta Novais | Q63385710 | ||
| Joel N Buxbaum | Q88718489 | ||
| Daniel R. Salomon | Q112670906 | ||
| P2093 | author name string | Thomas Whisenant | |
| Teresa Coelho | |||
| Terri Gelbart | |||
| P2860 | cites work | An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured | Q27634853 |
| Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action | Q27641464 | ||
| Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade | Q27679360 | ||
| Hepatic interleukin-7 expression regulates T cell responses | Q28238112 | ||
| Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins | Q28281645 | ||
| Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial | Q28304712 | ||
| Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response | Q29547299 | ||
| The mammalian unfolded protein response | Q29547400 | ||
| pROC: an open-source package for R and S+ to analyze and compare ROC curves | Q30050695 | ||
| Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses | Q33392252 | ||
| Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India | Q33417833 | ||
| Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate | Q33674118 | ||
| Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs | Q33716349 | ||
| Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial | Q33903527 | ||
| Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR). | Q33991826 | ||
| Trans-suppression of misfolding in an amyloid disease. | Q34092993 | ||
| Prevention of transthyretin amyloid disease by changing protein misfolding energetics. | Q34174171 | ||
| Transthyretin mutations in health and disease. | Q34298981 | ||
| Guideline of transthyretin-related hereditary amyloidosis for clinicians. | Q34328734 | ||
| Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. | Q34334873 | ||
| Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis | Q34336131 | ||
| Familial amyloid polyneuropathy: new developments in genetics and treatment | Q34405016 | ||
| Familial amyloidotic polyneuropathy | Q34413250 | ||
| Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity | Q34443897 | ||
| Protein phosphorylation controls translation rates | Q34513887 | ||
| Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. | Q34517861 | ||
| Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis | Q34581917 | ||
| Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. | Q34592571 | ||
| Environmental epidemiology and risk factors for autoimmune disease | Q35071032 | ||
| In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography | Q35119383 | ||
| Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes | Q35146621 | ||
| Parasitic infections in women and their consequences | Q35669731 | ||
| Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis? | Q35987887 | ||
| Targeting protein aggregation for the treatment of degenerative diseases | Q36235980 | ||
| Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins. | Q36640504 | ||
| Gender as risk factor for autoimmune diseases | Q36721434 | ||
| (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis | Q36740688 | ||
| Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis. | Q37153865 | ||
| Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy | Q37301237 | ||
| Power Calculations for General Linear Multivariate Models Including Repeated Measures Applications | Q37727538 | ||
| Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
| Increasing scientific power with statistical power | Q41094636 | ||
| Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells | Q42275424 | ||
| Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study | Q44171249 | ||
| Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants | Q44767199 | ||
| Interactions between the gonadal steroids and the immune system | Q46261265 | ||
| Online registry for mutations in hereditary amyloidosis including nomenclature recommendations | Q47590416 | ||
| Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria | Q48024015 | ||
| Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. | Q50119393 | ||
| Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. | Q50963773 | ||
| Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. | Q51812767 | ||
| Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). | Q52807508 | ||
| Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. | Q52933297 | ||
| The assumptions underlying the analysis of variance. | Q53054932 | ||
| Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. | Q53880179 | ||
| Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis | Q56985661 | ||
| Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience | Q57259363 | ||
| Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type) | Q57259458 | ||
| Protective Role of Anakinra Against Transthyretin-Mediated Axonal Loss and Cell Death in a Mouse Model of Familial Amyloidotic Polyneuropathy | Q60595531 | ||
| Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30) | Q68330233 | ||
| Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation | Q74045139 | ||
| The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay | Q74606880 | ||
| Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry | Q75265488 | ||
| Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations | Q79325396 | ||
| P433 | issue | 11 | |
| P921 | main subject | transthyretin amyloidosis | Q2844603 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 1792-1809 | |
| P577 | publication date | 2016-07-18 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures | |
| P478 | volume | 6 |
| Q55039669 | Curated compendium of human transcriptional biomarker data. |
| Q93111607 | Inflammatory profiling of patients with familial amyloid polyneuropathy |
| Q33685899 | Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin. |
| Q92884378 | Predictive model of response to tafamidis in hereditary ATTR polyneuropathy |
| Q47562649 | Transthyretin familial amyloid polyneuropathy: an update |
| Q64119031 | and modify age-at-onset in familial amyloid polyneuropathy patients |
Search more.